Insurance Type Influences Access to Biologics and Healthcare Utilization in Pediatric Crohn's Disease.

In this national sample of children with CD, publicly insured children were more likely to receive a biologic within 18 months of diagnosis compared to children with private insurance. At all points in time, publicly insured children also utilized emergency room services and required hospitalization at a significantly higher rate.